Prolactinoma

Last updated: November 01, 2022

Prolactinoma

test 4

test 4

Diabetes insipidus
Diabetes mellitus: Clinical
Diabetes mellitus
Diabetes mellitus: Pathology review
Graves disease
Hyperthyroidism: Nursing process (ADPIE)
Hyperthyroidism
Hyperthyroidism: Pathology review
Hyperparathyroidism
Hyperparathyroidism: Nursing
Hypopituitarism
Hypopituitarism: Clinical
Hypopituitarism: Pathology review
Hypothyroidism
Hypothyroidism: Nursing process (ADPIE)
Hypothyroidism: Pathology review
Metabolic acidosis
Metabolic alkalosis
Prolactinoma
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Anemia: Clinical
Macrocytic anemia: Pathology review
Aplastic anemia
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Disseminated intravascular coagulation
Acute disseminated encephalomyelitis
Hemophilia
Hemophilia: Nursing process (ADPIE)
Thrombocytopenia: Clinical
Heparin-induced thrombocytopenia
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Leukemia: Nursing process (ADPIE)
Chronic leukemia
Leukemias: Pathology review
Acute leukemia
Leukemia: Clinical
Lymphomas: Pathology review
Lymphoma: Clinical
Hodgkin lymphoma
Non-Hodgkin lymphoma
Lymphatic system anatomy and physiology
Multiple endocrine neoplasia: Pathology review
Multiple endocrine neoplasia
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Sickle cell disease: Nursing process (ADPIE)
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Von Willebrand disease
von Hippel-Lindau disease
Allergic rhinitis
Antibody classes
Pediatric allergies: Clinical
Food allergies and EpiPens: Information for patients and families (The Primary School)
Anaphylaxis: Nursing process (ADPIE)
Anaphylaxis
Appendicitis: Nursing process (ADPIE)
Appendicitis: Pathology review
Appendicitis
Appendicitis: Clinical
Gonorrhea and chlamydia: Nursing process (ADPIE)
Chlamydia pneumoniae
Chlamydia trachomatis
Clostridium difficile (Pseudomembranous colitis)
Viral hepatitis: Pathology review
Viral hepatitis: Clinical
Hepatitis C virus
Viral hepatitis
Hepatitis A and Hepatitis E virus
Herpes simplex virus
Herpesvirus medications
Human parainfluenza viruses
HIV (AIDS)
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Human papillomavirus
Influenza virus
The flu vaccine: Information for patients and families
Vaccinations
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Borrelia burgdorferi (Lyme disease)
Lyme disease: Nursing process (ADPIE)
Lyme Disease
Meningitis: Nursing process (ADPIE)
Meningitis
Meningitis, encephalitis and brain abscesses: Clinical
Epstein-Barr virus (Infectious mononucleosis)
Pelvic inflammatory disease
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Urinary tract infections (UTIs): Nursing process (ADPIE)
Urinary tract infections: Pathology review
Lower urinary tract infection
Urinary tract infections: Clinical
Gardnerella vaginalis (Bacterial vaginosis)
Chickenpox (Varicella): Nursing process (ADPIE)
Varicella zoster virus

Flashcards

Prolactinoma

0 of 6 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A 32-year-old man comes to his outpatient provider because of headaches that began five-months ago. The patient reports that the headaches are worse in the morning and improve over the day. In addition, the patient endorses reduced body hair. He does not use any medications. Temperature is 37.4°C (99.3°F), pulse is 68/min, respirations are 20/min, and blood pressure is 125/72 mmHg. Physical exam is notable for restricted peripheral vision and white watery discharge from the nipples. Further review of the patient’s history will most likely reveal which of the following findings?

Transcript

Watch video only

With prolactinoma, prolactin refers to the endocrine hormone secreted by the pituitary gland and -oma refers to a tumor.

So a prolactinoma is a benign tumor, or adenoma, of the pituitary gland that secretes excess prolactin.

Normally, the pituitary is a pea-sized gland, hanging by a stalk from the base of the brain.

It sits just behind the eyes near something called the optic chiasm, which is where the optic nerves cross.

The anterior pituitary, which is the front of the pituitary gland, contains a few different types of cells, and each of which secretes a different hormone.

One group of cells in the anterior pituitary are called lactotrophs and they secrete prolactin.

Prolactin stimulates breast milk production.

Another group of cells are the gonadotrophs and they secrete two gonadotropic hormones - luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH, both of which stimulate the ovaries in women which make estrogen and stimulate the testes in men which make testosterone.

Prolactin release is controlled by something called the hypothalamus, which is a structure at the base of the brain just above the pituitary gland.

It makes two key hormones, thyrotropin-releasing hormone which increases prolactin release, and dopamine, which inhibits the prolactin release and actually overrides the stimulatory effect of thyrotropin-releasing hormone.

That’s why dopamine is known as prolactin-inhibiting factor, and why it’s constantly released to prevent prolactin release in anyone that’s not pregnant.

High levels of prolactin in the blood sends a negative feedback signal to the hypothalamus, making it release more dopamine which then decreases prolactin levels.

High levels of prolactin can also signal the hypothalamus to decrease the secretion of gonadotropin releasing hormone or GnRH.

Gonadotropin releasing hormone acts on the anterior pituitary to make follicle stimulating hormone and luteinizing hormone or FSH and LH.

Now, during pregnancy the anterior pituitary gland releases prolactin and the placenta releases human placental lactogen and progesterone, and all three of these hormones stimulate the growth of more glandular tissue in the breast to produce milk.

Prolactinomas are functional tumors, meaning they secrete high levels of prolactin, and they typically form when there’s a mutation in the lactotroph cells of the anterior pituitary that allows the cells to divide uncontrollably.

The key is in the size of these things. Prolactinomas that are less than 10 mm in diameter are considered microprolactinomas, whereas those greater than 10 mm are known as macroprolactinomas.

Now, macroprolactinomas can compress surrounding structures like the meninges, which is the protective layer overlying the brain and that typically causes pain when it’s stretched.

Also, an enlarged pituitary gland can compress the optic nerves as they cross at the optic chiasm.

This can cause visual problems as well as affect a person’s ability to view things that are in the temporal, or the outermost portion, of the visual field in both eyes, and this is called “bitemporal hemianopia”.

Another name for this is tunnel vision because the center of your vision is clear but everything in the periphery is dark, kind of like looking through a tunnel, I suppose.

Key Takeaways

A prolactinoma is a benign pituitary gland tumor that produces high levels of the hormone prolactin. Prolactin then suppresses the gonadotropin-releasing hormone resulting in symptoms like amenorrhea, galactorrhea, hypogonadism, gynecomastia, and erectile dysfunction in males. Treatment involves the use of dopamine agonist agents like bromocriptine which reduces the size of the tumor and lowers prolactin levels. In some cases, surgery or radiation therapy may also be required.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy" Nature Clinical Practice Endocrinology & Metabolism (2006)
  7. "Demographic differences in incidence for pituitary adenoma" Pituitary (2010)